Ivabradine to Prevent Anthracycline-induced Cardiotoxicity

Status:
Unknown status

Trial end date:
2020-12-31

Target enrollment:

Participant gender:

The aim of this study is to investigate protective effects of ivabradine in adult cancer patients undergoing anthracycline-based chemotherapy.

Phase 3

Vilnius University